Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial

@article{Ludvigsson2010ExtendedEO,
  title={Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial},
  author={J. Ludvigsson and Martin Hjorth and Mikael Ch{\'e}ramy and Stina Axelsson and Mathilde Pihl and Gun Forsander and N.-{\"O}. Nilsson and B.-O. Samuelsson and Trevor Wood and Jan {\AA}man and Eva {\"O}rtqvist and Raquel Casas},
  journal={Diabetologia},
  year={2010},
  volume={54},
  pages={634-640}
}
The aim of this study was to investigate the safety and efficacy of alum formulated glutamic acid decarboxylase GAD65 (GAD-alum) treatment of children and adolescents with type 1 diabetes after 4 years of follow-up. Seventy children and adolescents aged 10–18 years with recent onset type 1 diabetes participated in a phase II, double-blind, randomised placebo-controlled clinical trial. Patients identified as possible participants attended one of eight clinics in Sweden to receive information… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Similar Papers

Loading similar papers…